Kimball Acquires Helvoet to Expand Medical CMO Platform
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 01 2026
0mins
Source: Newsfilter
- Acquisition Overview: Kimball Electronics has acquired Helvoet for €90 million (approximately $103 million), a transaction expected to positively impact adjusted earnings for fiscal 2027, driving low double-digit sales growth in the medical vertical.
- Market Expansion Strategy: This acquisition expands Kimball's manufacturing footprint into Europe and India, leveraging the new Indianapolis facility to meet near-term U.S. demand, thereby enhancing the company's competitiveness in the global medical market.
- Complementary Customer Base: Helvoet's clientele includes blue-chip medical companies that complement Kimball's portfolio, creating opportunities for expanded program wins and potential vertical integration, further increasing market share.
- Management Outlook: Kimball's management plans to host a conference call on July 1, 2026, to discuss acquisition details and answer related questions, demonstrating the company's confidence and strategic direction for future growth.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy KE?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on KE
Wall Street analysts forecast KE stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 24.630
Low
32.00
Averages
32.00
High
32.00
Current: 24.630
Low
32.00
Averages
32.00
High
32.00
About KE
Kimball Electronics, Inc. is a global, multifaceted manufacturer offering electronics manufacturing services (EMS) and contract manufacturing organization (CMO) solutions. It provides electronics manufacturing services, including engineering and supply chain support, to customers in the automotive, medical, and industrial end markets. Its CMO solutions include operations such as precision molded plastics and cold chain management to drug integration. The Company provides contract manufacturing services, including engineering and supply chain support, for the production of electronic assemblies and other products including medical devices, medical disposables, precision molded plastics, and complete device assembly primarily in automotive, medical, and industrial applications. The Company has acquired a Contract Development and Manufacturing Organization (CDMO), based in Europe and with operations in India focused on microfluidics, diagnostics, and drug delivery.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Iran Missile Attack Causes Industrial Stocks to Fall
- Oil Price Surge: Iran's missile attack on commercial tankers in the Strait of Hormuz has pushed Brent crude prices toward $75 and WTI to around $71, directly compressing operating margins in sectors like airlines, trucking, and machinery, leading to an overall decline of about 2% in the industrial sector.
- Market Overreaction: While industrial stocks broadly declined, the market's reaction appeared overly severe, particularly with electronic components and renewables companies like Corning and Enphase experiencing drops of 7-9%, indicating heightened sensitivity to geopolitical risks among investors.
- Fed Policy Impact: The hawkish stance of new Fed Chair Kevin Warsh has raised expectations for a 2026 rate hike, pushing the 10-year Treasury yield to approximately 4.47%, which further increases financing costs for the industrial sector, exacerbating investor concerns about future profitability.
- Investment Opportunity Assessment: Despite Kimball Solutions' stock price falling 13.3% year-to-date, the volatility in the market presents investors with opportunities to buy high-quality stocks at lower prices, suggesting that long-term investors may benefit from the current market conditions.
See More
Kimball Acquires Helvoet to Expand Medical CMO Platform
- Acquisition Overview: Kimball Electronics has acquired Helvoet for €90 million (approximately $103 million), a transaction expected to positively impact adjusted earnings for fiscal 2027, driving low double-digit sales growth in the medical vertical.
- Market Expansion Strategy: This acquisition expands Kimball's manufacturing footprint into Europe and India, leveraging the new Indianapolis facility to meet near-term U.S. demand, thereby enhancing the company's competitiveness in the global medical market.
- Complementary Customer Base: Helvoet's clientele includes blue-chip medical companies that complement Kimball's portfolio, creating opportunities for expanded program wins and potential vertical integration, further increasing market share.
- Management Outlook: Kimball's management plans to host a conference call on July 1, 2026, to discuss acquisition details and answer related questions, demonstrating the company's confidence and strategic direction for future growth.
See More
Kimball Electronics Q1 2026 Earnings Report Analysis
- Revenue Decline: Kimball Electronics reported Q1 2026 revenue of $352.9 million, reflecting a 5.8% year-on-year decline and missing analyst expectations of $356.3 million, indicating potential investor concerns due to weakness in automotive and industrial markets.
- Medical Segment Growth: Despite the overall revenue drop, the Medical segment showed sequential growth, with CEO Ric Phillips emphasizing its critical role in stabilizing results, suggesting strong demand in the medical market may provide a buffer for the company.
- Profitability Metrics: Adjusted EPS was $0.33, in line with expectations, while adjusted EBITDA stood at $22.83 million with a 6.5% margin, slightly below forecasts, reflecting challenges in cost management that could impact future profitability.
- Future Outlook: Management reaffirmed full-year revenue guidance of $1.43 billion, and despite market challenges, the company is actively ramping up production at the new Indianapolis facility, which is expected to enhance capacity and margins, demonstrating confidence in future growth.
See More
Kimball Electronics Q3 FY 2026 Earnings Call Insights
- Sales Growth: Kimball Electronics reported net sales of $353 million in Q3, reflecting a 3.4% increase from the previous quarter, with the medical segment growing by 10%, indicating strong demand that is expected to drive future revenue growth.
- Stable Margins: The gross margin rate for Q3 was 7.9%, with adjusted operating income at $14.8 million or 4.2% of net sales; despite facing gross margin pressure in FY '27, the company is making strategic investments to enhance operational efficiency.
- Future Outlook: The company reaffirmed its revenue guidance for FY 2026 in the range of $1.4 billion to $1.46 billion, expecting adjusted operating income margins to be between 4.2% and 4.5%, demonstrating management's confidence in future performance.
- Investment and Buyback: In Q3, Kimball Electronics repurchased 165,000 shares for $4 million, leaving $6.5 million remaining in its buyback program, indicating a proactive approach to capital allocation aimed at enhancing shareholder value.
See More
Kimball Electronics Q3 Earnings Miss Expectations
- Disappointing Performance: Kimball Electronics reported a Q3 non-GAAP EPS of $0.33, missing expectations by $0.01, indicating pressure on profitability that may affect investor confidence.
- Revenue Decline: The company’s revenue for Q3 was $352.9 million, down 5.8% year-over-year and falling short of expectations, reflecting weak market demand and increased competition that could pressure future performance.
- Fiscal Year 2026 Guidance: Kimball Electronics projects net sales for FY 2026 to be between $1.4 billion and $1.46 billion, with adjusted operating income estimated at 4.2% to 4.5% of net sales, indicating cautious optimism for future growth.
- Capital Expenditure Plans: The company plans to invest $50 million to $60 million in capital expenditures for FY 2026, aimed at enhancing production capacity and technological capabilities to support future business growth.
See More
Kimball Electronics Q3 Earnings Announcement Scheduled
- Earnings Release Date: Kimball Electronics is set to announce its Q3 earnings on May 5th after market close, with a consensus EPS estimate of $0.34, reflecting a 25.9% year-over-year increase, indicating ongoing improvement in profitability.
- Revenue Outlook Analysis: Despite the optimistic EPS forecast, the revenue estimate stands at $356.27 million, representing a 4.9% year-over-year decline, which suggests challenges in revenue growth that could impact overall market confidence.
- Historical Performance Review: Over the past two years, Kimball Electronics has beaten EPS estimates 63% of the time and revenue estimates 50% of the time, demonstrating relative stability in managing market expectations, which may bolster investor confidence.
- Expectation Revision Dynamics: In the last three months, EPS estimates have seen three upward revisions and one downward revision, while revenue estimates have also experienced three upward revisions and one downward revision, indicating some divergence in analysts' views on the company's future performance.
See More
Iran Missile Attack Causes Industrial Stocks to Fall
- Oil Price Surge: Iran's missile attack on commercial tankers in the Strait of Hormuz has pushed Brent crude prices toward $75 and WTI to around $71, directly compressing operating margins in sectors like airlines, trucking, and machinery, leading to an overall decline of about 2% in the industrial sector.
- Market Overreaction: While industrial stocks broadly declined, the market's reaction appeared overly severe, particularly with electronic components and renewables companies like Corning and Enphase experiencing drops of 7-9%, indicating heightened sensitivity to geopolitical risks among investors.
- Fed Policy Impact: The hawkish stance of new Fed Chair Kevin Warsh has raised expectations for a 2026 rate hike, pushing the 10-year Treasury yield to approximately 4.47%, which further increases financing costs for the industrial sector, exacerbating investor concerns about future profitability.
- Investment Opportunity Assessment: Despite Kimball Solutions' stock price falling 13.3% year-to-date, the volatility in the market presents investors with opportunities to buy high-quality stocks at lower prices, suggesting that long-term investors may benefit from the current market conditions.
See More
Kimball Acquires Helvoet to Expand Medical CMO Platform
- Acquisition Overview: Kimball Electronics has acquired Helvoet for €90 million (approximately $103 million), a transaction expected to positively impact adjusted earnings for fiscal 2027, driving low double-digit sales growth in the medical vertical.
- Market Expansion Strategy: This acquisition expands Kimball's manufacturing footprint into Europe and India, leveraging the new Indianapolis facility to meet near-term U.S. demand, thereby enhancing the company's competitiveness in the global medical market.
- Complementary Customer Base: Helvoet's clientele includes blue-chip medical companies that complement Kimball's portfolio, creating opportunities for expanded program wins and potential vertical integration, further increasing market share.
- Management Outlook: Kimball's management plans to host a conference call on July 1, 2026, to discuss acquisition details and answer related questions, demonstrating the company's confidence and strategic direction for future growth.
See More
Kimball Electronics Q1 2026 Earnings Report Analysis
- Revenue Decline: Kimball Electronics reported Q1 2026 revenue of $352.9 million, reflecting a 5.8% year-on-year decline and missing analyst expectations of $356.3 million, indicating potential investor concerns due to weakness in automotive and industrial markets.
- Medical Segment Growth: Despite the overall revenue drop, the Medical segment showed sequential growth, with CEO Ric Phillips emphasizing its critical role in stabilizing results, suggesting strong demand in the medical market may provide a buffer for the company.
- Profitability Metrics: Adjusted EPS was $0.33, in line with expectations, while adjusted EBITDA stood at $22.83 million with a 6.5% margin, slightly below forecasts, reflecting challenges in cost management that could impact future profitability.
- Future Outlook: Management reaffirmed full-year revenue guidance of $1.43 billion, and despite market challenges, the company is actively ramping up production at the new Indianapolis facility, which is expected to enhance capacity and margins, demonstrating confidence in future growth.
See More
Kimball Electronics Q3 FY 2026 Earnings Call Insights
- Sales Growth: Kimball Electronics reported net sales of $353 million in Q3, reflecting a 3.4% increase from the previous quarter, with the medical segment growing by 10%, indicating strong demand that is expected to drive future revenue growth.
- Stable Margins: The gross margin rate for Q3 was 7.9%, with adjusted operating income at $14.8 million or 4.2% of net sales; despite facing gross margin pressure in FY '27, the company is making strategic investments to enhance operational efficiency.
- Future Outlook: The company reaffirmed its revenue guidance for FY 2026 in the range of $1.4 billion to $1.46 billion, expecting adjusted operating income margins to be between 4.2% and 4.5%, demonstrating management's confidence in future performance.
- Investment and Buyback: In Q3, Kimball Electronics repurchased 165,000 shares for $4 million, leaving $6.5 million remaining in its buyback program, indicating a proactive approach to capital allocation aimed at enhancing shareholder value.
See More
Kimball Electronics Q3 Earnings Miss Expectations
- Disappointing Performance: Kimball Electronics reported a Q3 non-GAAP EPS of $0.33, missing expectations by $0.01, indicating pressure on profitability that may affect investor confidence.
- Revenue Decline: The company’s revenue for Q3 was $352.9 million, down 5.8% year-over-year and falling short of expectations, reflecting weak market demand and increased competition that could pressure future performance.
- Fiscal Year 2026 Guidance: Kimball Electronics projects net sales for FY 2026 to be between $1.4 billion and $1.46 billion, with adjusted operating income estimated at 4.2% to 4.5% of net sales, indicating cautious optimism for future growth.
- Capital Expenditure Plans: The company plans to invest $50 million to $60 million in capital expenditures for FY 2026, aimed at enhancing production capacity and technological capabilities to support future business growth.
See More
Kimball Electronics Q3 Earnings Announcement Scheduled
- Earnings Release Date: Kimball Electronics is set to announce its Q3 earnings on May 5th after market close, with a consensus EPS estimate of $0.34, reflecting a 25.9% year-over-year increase, indicating ongoing improvement in profitability.
- Revenue Outlook Analysis: Despite the optimistic EPS forecast, the revenue estimate stands at $356.27 million, representing a 4.9% year-over-year decline, which suggests challenges in revenue growth that could impact overall market confidence.
- Historical Performance Review: Over the past two years, Kimball Electronics has beaten EPS estimates 63% of the time and revenue estimates 50% of the time, demonstrating relative stability in managing market expectations, which may bolster investor confidence.
- Expectation Revision Dynamics: In the last three months, EPS estimates have seen three upward revisions and one downward revision, while revenue estimates have also experienced three upward revisions and one downward revision, indicating some divergence in analysts' views on the company's future performance.
See More
